These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Arguments for a uniform pathogenesis of polyetiologic arterial occlusions]. Hess H; Frost H Verh Dtsch Ges Kreislaufforsch; 1969; 35():333-40. PubMed ID: 5380611 [No Abstract] [Full Text] [Related]
6. Upper thoracic sympathectomy. Immediate and late results. Tsur N; Adar R; Bechor I; Bogokowsky H; Mozes M Isr J Med Sci; 1973 Jan; 9(1):53-8. PubMed ID: 4722514 [No Abstract] [Full Text] [Related]
7. [Thromboangiitis obliterans--a symptom or a disease? Morphologic studies on 38 cases]. Leu HJ Med Welt; 1975 Sep; 26(37):1661-5. PubMed ID: 1177731 [No Abstract] [Full Text] [Related]
8. [Raynaud's disease and syndromes]. Montorsi W Minerva Med; 1974 Nov; 65(78):4087-111. PubMed ID: 4431575 [No Abstract] [Full Text] [Related]
9. [Hyperproduction of immunoglobulin E in occlusive diseases of the peripheral arteries]. Baranov AA; Shilkina NP; Masenko VP; Kushekbaeva AE; Nasonov EL; Lebedin IuG Klin Med (Mosk); 1991 Apr; 69(4):45-8. PubMed ID: 1865650 [No Abstract] [Full Text] [Related]
10. [Etiopathogenic aspects of chronic peripheral arteriopathies and their diagnosis]. Moga A; Vlaicu R Med Interna (Bucur); 1967 Jul; 19(7):859-64. PubMed ID: 6052172 [No Abstract] [Full Text] [Related]
11. [Smoking--one of the risk factors in the development of occlusive disease]. Puchmayer V; Schoop W; Jacob E; Bulvas M; Vanderbeke O Vnitr Lek; 1979 Mar; 25(3):225-34. PubMed ID: 433166 [No Abstract] [Full Text] [Related]
12. Smoker with Raynaud phenomenon and painful nodules on the legs. Floristán MU; Almodovar R; Salamanca FJ Actas Dermosifiliogr; 2013 Oct; 104(8):717-8. PubMed ID: 23938099 [No Abstract] [Full Text] [Related]
13. [Role of several risk factors in chronic obliterating arteriopathies of the extremities]. Stăncioiu N Med Interna (Bucur); 1971 Dec; 23(12):1415-26. PubMed ID: 5159278 [No Abstract] [Full Text] [Related]
15. [Effect of surheme on improved blood flow in limbs]. Wesolowski J; Hubl S; Godziemba-Maliszewska E Wiad Lek; 1972 Jul; 25(14):1297-300. PubMed ID: 5054661 [No Abstract] [Full Text] [Related]
16. [A method of correction of hemorheological disorders in patients with thrombobliterating diseases of the peripheral arteries of the limbs]. Litmanovich KIu; Mel'nikova VN; Fregatova LM; Kargin VD; Egorova LV Vestn Khir Im I I Grek; 1985 Jul; 135(7):96-9. PubMed ID: 4060495 [TBL] [Abstract][Full Text] [Related]
17. [Use of a new sympatholytic drug in therapy of chronic peripheral obliterating artery diseases]. Vittori C; Taborelli G; Taborelli R Minerva Cardioangiol; 1965 Sep; 13(9):585-91. PubMed ID: 5851172 [No Abstract] [Full Text] [Related]
18. [Arteriosclerosis obliterans and Buerger's disease]. Ishimaru S; Yao Y Ryoikibetsu Shokogun Shirizu; 1996; (14):553-6. PubMed ID: 9047930 [No Abstract] [Full Text] [Related]
19. Buerger's disease in Israel. Investigations on carboxyhemoglobin and serum cholesterol levels after smoking. Kjeldsen K; Mozes M Acta Chir Scand; 1969; 135(6):495-8. PubMed ID: 5368937 [No Abstract] [Full Text] [Related]
20. [Role of lysosomal enzymes in the pathogenesis of peripheral arterial diseases]. Knapik-Kordecka M Pol Arch Med Wewn; 1983 Jun; 69(6):401-6. PubMed ID: 6359085 [No Abstract] [Full Text] [Related] [Next] [New Search]